...BRCA1/BRCA2 and life insurance or disability pension, the premium paid by persons with susceptibility to HNPCC varied be...
...BRCA1 or BRCA2 will develop breast cancer.,We review the advantages and disadvantages of the kin-cohort design and focus...
...BRCA1 or BRCA2 mutations are segregating. Most "hereditary" cancers are "sporadic.",The collection of DNA, as well as da...
...BRCA1 in human cells. The entire isolation procedure of BRCA1 described in this paper can be accomplished in approximate...
...BRCA1 mutation carriers, and 36 (55%) were non-carriers of any of the predominant Jewish mutations in BRCA1 or BRCA2 (sp...
...BRCA1 and BRCA2 in Canadian Jewish women with breast cancer. A self-administered questionnaire was developed and distrib...
...BRCA1/BRCA2) and hereditary nonpolyposis colon cancer (HNPCC).,Questionnaire survey of the membership of the National So...
...BRCA1 and BRCA2 mutations, which are associated with an increased risk of breast and ovarian cancer, can have long-term ...
...BRCA1 protein and one of the BRCA2 protein. One of the BRCA1 mutations and the only BRCA2 mutation are prevelant among c...
...BRCA1 protein (BRCA1+), six mutations with unknown consequences on the BRCA1 protein, and eleven mutations corresponding...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2025.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
